B2065
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for B2065, covering 2026-01-28 to 2026-01-28. Get the full timeline:
Most recent: Clinical Trial Update: A Study of the Safety, Tolerability and Preliminary Efficacy of B2065 in Patients With Acute Ischemic Stroke. [Phase 1, Phase 2]